What is Repare Therapeutics Inc?
, a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 114.24M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.